Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas

p53 Expression Is a Strong Marker of Inferior Survival in De Novo Diffuse Large B-Cell Lymphoma and May Have Enhanced Negative Effect With MYC Coexpression

(2014) Yi Xie et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas

(2014) Christine Haberler et al.   CLINICAL NEUROPATHOLOGY

Targeting the untargetable: recent advances in the selective chemical modulation of protein phosphatase-1 activity

(2013) Jayanta Chatterjee et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Glioblastoma and Other Malignant Gliomas

(2013) Antonio Omuro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit in vitro

(2012) Jun-yang Li et al.   ACTA PHARMACOLOGICA SINICA

IDH1 Mutations in Diffusely Infiltrating Astrocytomas

(2012) Balaram Thota et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx

(2012) Zengxin Lu et al.   CELLULAR SIGNALLING

Exploiting the selectivity of protein phosphatase 1 for pharmacological intervention

(2012) Pavel Tsaytler et al.   FEBS Journal

Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia

(2012) Christoph P. Hofstetter et al.   PLoS One

Glioblastoma-Specific Protein Interaction Network Identifies PP1A and CSK21 as Connecting Molecules between Cell Cycle-Associated Genes

(2010) J. Ladha et al.   CANCER RESEARCH

Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients

(2010) M. R. Srividya et al.   JOURNAL OF CLINICAL PATHOLOGY

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

(2009) Michael Weller et al.   JOURNAL OF CLINICAL ONCOLOGY

PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation

(2009) Judy Qiju Wu et al.   NATURE CELL BIOLOGY

Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms

(2009) Jie Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis

(2008) S. P. Reddy et al.   CLINICAL CANCER RESEARCH

Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

(2008) Kathleen R. Lamborn et al.   NEURO-ONCOLOGY

Characterization of the p53 Response to Oncogene-Induced Senescence

(2008) Lidia Ruiz et al.   PLoS One